41 related articles for article (PubMed ID: 31796507)
1. Eribulin Suppresses Clear Cell Sarcoma Growth by Inhibiting Cell Proliferation and Inducing Melanocytic Differentiation Both Directly and Via Vascular Remodeling.
Nakai S; Tamiya H; Imura Y; Nakai T; Yasuda N; Wakamatsu T; Tanaka T; Outani H; Takenaka S; Hamada K; Myoui A; Araki N; Ueda T; Yoshikawa H; Naka N
Mol Cancer Ther; 2020 Mar; 19(3):742-754. PubMed ID: 31796507
[TBL] [Abstract][Full Text] [Related]
2. Eribulin induces tumor vascular remodeling through intussusceptive angiogenesis in a sarcoma xenograft model.
Taguchi E; Horiuchi K; Senoo A; Susa M; Inoue M; Ishizaka T; Rikitake H; Matsuhashi Y; Chiba K
Biochem Biophys Res Commun; 2021 Sep; 570():89-95. PubMed ID: 34274851
[TBL] [Abstract][Full Text] [Related]
3. Activity of Eribulin in a Primary Culture of Well-Differentiated/Dedifferentiated Adipocytic Sarcoma.
De Vita A; Miserocchi G; Recine F; Mercatali L; Pieri F; Medri L; Bongiovanni A; Cavaliere D; Liverani C; Spadazzi C; Amadori D; Ibrahim T
Molecules; 2016 Dec; 21(12):. PubMed ID: 27918490
[TBL] [Abstract][Full Text] [Related]
4. MITF::CREM-rearranged tumor: a novel group of cutaneous tumors with melanocytic differentiation.
Kalmykova A; Mosaieby E; Kacerovská D; Baranovska-Andrigo V; Martínek P; Smahová S; Michal M; Michal M
Virchows Arch; 2023 Oct; 483(4):569-575. PubMed ID: 37550584
[TBL] [Abstract][Full Text] [Related]
5. Eribulin Inhibits Osteosarcoma in a Clinically-accurate Bone-tumor-insertion PDOX Mouse Model.
Wu NF; Yamamoto J; Aoki Y; Bouvet M; Hoffman RM
Anticancer Res; 2021 Apr; 41(4):1779-1784. PubMed ID: 33813382
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Eribulin Combined with Irinotecan for Treatment of Pediatric Cancer Xenografts.
Robles AJ; Kurmasheva RT; Bandyopadhyay A; Phelps DA; Erickson SW; Lai Z; Kurmashev D; Chen Y; Smith MA; Houghton PJ
Clin Cancer Res; 2020 Jun; 26(12):3012-3023. PubMed ID: 32184294
[TBL] [Abstract][Full Text] [Related]
7. TP53 Null Mutations Identify Lung Cancer Cell Lines with Highest Sensitivity to the Nontaxane Microtubule Inhibitor Eribulin.
Hinz TK; Kalkur R; Rabinovitch J; Hinkle W; Heasley LE
Mol Pharmacol; 2021 Aug; 100(2):144-154. PubMed ID: 34031188
[TBL] [Abstract][Full Text] [Related]
8. Involvement of ferroptosis in eribulin-induced cytotoxicity in ovarian clear cell carcinoma.
Azumi M; Kusama K; Yoshie M; Nakano S; Tsuru A; Kato T; Tamura K
Eur J Pharmacol; 2024 May; 971():176544. PubMed ID: 38552939
[TBL] [Abstract][Full Text] [Related]
9. Eribulin Regresses a Doxorubicin-resistant Dedifferentiated Liposarcoma in a Patient-derived Orthotopic Xenograft Mouse Model.
Igarashi K; Kawaguchi K; Kiyuna T; Miyake K; Higuchi T; Yamamoto N; Hayashi K; Kimura H; Miwa S; Singh SR; Tsuchiya H; Hoffman RM
Cancer Genomics Proteomics; 2020; 17(4):351-358. PubMed ID: 32576580
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Gemcitabine-based Chemotherapy in Clear Cell Sarcoma of Soft Tissue.
Cojocaru E; Thway K; Fisher C; Messiou C; Zaidi S; Miah AB; Benson C; Gennatas S; Huang P; Jones RL
Anticancer Res; 2020 Dec; 40(12):7003-7007. PubMed ID: 33288595
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin enhances the efficacy of nilotinib in chronic myeloid leukaemia by post-translational modification and drug transporter modulation.
Asari K; Sun WT; Kok ZH; Lam YH; Ng BL; Saunders V; White DL; Chuah C; Xiang W
Anticancer Drugs; 2021 Jun; 32(5):526-536. PubMed ID: 33587350
[TBL] [Abstract][Full Text] [Related]
12. Investigating Programmed Cell Death and Tumor Invasion in a Three-Dimensional (3D) Microfluidic Model of Glioblastoma.
Samiei E; Seyfoori A; Toyota B; Ghavami S; Akbari M
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365781
[TBL] [Abstract][Full Text] [Related]
13. Response to eribulin in a patient with metastatic uterine leiomyosarcoma: a case report.
Aliberti S; Miano S; Tolomeo F; Merlini A; Aglietta M; Grignani G
Future Oncol; 2020 Jan; 16(1s):15-19. PubMed ID: 31916842
[TBL] [Abstract][Full Text] [Related]
14. Pre-treatment Neutrophil-to-Lymphocyte Ratio Predicts Efficacy of Eribulin for Soft-tissue Sarcoma.
Sato Y; Nakano K; Fukuda N; Wang X; Urasaki T; Ohmoto A; Yunokawa M; Ono M; Tomomatsu J; Hayakawa K; Funauchi Y; Tanizawa T; Ae K; Matsumoto S; Takahashi S
Anticancer Res; 2021 Jan; 41(1):527-532. PubMed ID: 33419852
[TBL] [Abstract][Full Text] [Related]
15. Clear Cell Sarcoma of the Achilles Tendon: A Case Report.
Ngissah R; Choi JY; Kim HS; Lee DJ; Park JH; Suh JS
J Foot Ankle Surg; 2020; 59(5):1076-1078. PubMed ID: 32359715
[TBL] [Abstract][Full Text] [Related]
16. Revisiting 'Hallmarks of Cancer' In Sarcomas.
Honoki K; Tsujiuchi T; Kishi S; Kuniyasu H
J Cancer; 2024; 15(7):1786-1804. PubMed ID: 38434982
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Eribulin Plus Gemcitabine Combination in L-Sarcomas.
López-Álvarez M; González-Aguilera C; Moura DS; Sánchez-Bustos P; Mondaza-Hernández JL; Martín-Ruiz M; Renshaw M; Ramos R; Castilla C; Blanco-Alcaina E; Hindi N; Martín-Broto J
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614121
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Eribulin in Soft Tissue Sarcomas.
Phillips E; Jones RL; Huang P; Digklia A
Front Pharmacol; 2022; 13():869754. PubMed ID: 35444542
[TBL] [Abstract][Full Text] [Related]
19. The Dual Effect of the BMP9-ALK1 Pathway in Blood Vessels: An Opportunity for Cancer Therapy Improvement?
Ayuso-Íñigo B; Méndez-García L; Pericacho M; Muñoz-Félix JM
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771575
[TBL] [Abstract][Full Text] [Related]
20. Eribulin Provides a Remarkable Effect in Trabectedin-Resistant Myxoid Liposarcoma.
Tamiya H; Sabe H; Yamashita K; Imura Y; Wakamatsu T; Takenaka S
Case Rep Orthop; 2020; 2020():8873185. PubMed ID: 33274094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
